Account
Insider Insights
26.05.2022
G-BA awards highest rating to Trodelvy

The drug was judged to offer an indication of major additional benefit in adult patients with advanc...

Read more
Insider Insights
04.05.2022
The European Health Data Space launch

The EHDS will integrate three main product markets for primary use of health data: electronic health...

Read more
Insider Insights
04.05.2022
UK second lowest across major health outcomes

The data is derived from the Organisation for Economic Co-operation and Development (OECD) Health St...

Read more
Insider Insights
05.04.2022
IPCEI to promote development of gene and cell ther

The IPCEI was signed to address the need to equip Europe with a strong, innovative and export-friend...

Read more
Insider Insights
24.03.2022
“First of its kind” MAA leads to NICE approval

The draft final guidance reverses previous guidance issued in November 2021 rejecting the drug for r...

Read more
Insider Insights
09.03.2022
Requirement lifted for a number of products

Paracetamol and ibuprofen combinations are set to become available in pharmacies without a prescript...

Read more
Insider Insights
17.02.2022
Paracetamol and Ibuprofen combination available

The switch from prescription to non-prescription status was recommended by the Federal Institute for...

Read more
Insider Insights
09.02.2022
CMA fines firms 35 million

The actions of the companies meant that from December 2013 to December 2017, the price paid by the N...

Read more
Insider Insights
01.02.2022
Self-care market growth

According to the association, the growth in the market was expected and can be explained by two fact...

Read more
Articles
06.10.2021
PMA Perspective Q3 2021

Insights from pharmaceuticals, market access and Team Remap Q3 2021.

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.